Luminex Corporation | Complexity Simplified.

#soliloquy-container-14815{opacity:1}#soliloquy-container-14815 li > .soliloquy-caption{display:none}#soliloquy-container-14815 li:first-child > .soliloquy-caption{display:block} ARIES® MRSA Assay

Clinical

Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Research

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More

Luminex® Blog

METHODS Special Issue: Multiplexing Enables More Robust Surveillance for Avian Influenza

In the journal Methods, scientists from Wageningen Bioveterinary Research report the development of a multiplex assay for avian influenza. The assay is built on Luminex’s xMAP® Technology, and allows for serotyping all 16 hemagglutinin (HA) and 9 neuraminidase (NA) protein subtypes simultaneously.

Continue Reading >

Visit our blog >

xMAP® Technology

Luminex xMAP® Technology Overview

Clinical Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.Read More Research Our xMAP® Technology and its flexibl

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >